Finding a treatment for Parkinson's disease dementia

September 2, 2015 by Kate Bourne

University of Adelaide neuroscientists are leading a world-first study into a form of dementia experienced by many Parkinson's disease suffers, which is expected to ultimately lead to a new therapy for the condition.

Speaking in Parkinson's Awareness Week (1-7 September), Dr Lyndsey Collins-Praino, from the University of Adelaide's School of Medicine, says so much remains unknown about Parkinson's disease dementia and there is an urgent need for effective treatments.

"Parkinson's disease is characterised by four major motor symptoms: resting tremor, bradykinesia (slow movement), postural instability and rigidity. In addition to the seen in Parkinson's disease, many patients also suffer from some degree of cognitive impairment, which can range from mild impairment to dementia," says Dr Collins-Praino.

"Within 20 years of diagnosis of Parkinson's disease over 80% of patients develop dementia. Parkinson's disease dementia, which includes a variety of behavioural and cognitive impairments, dramatically decreases the quality of a patient's life.

"Current pharmacological therapies for Parkinson's disease dementia have varying efficacy and may actually worsen some of the motor symptoms," she says. "Despite the growing recognition of cognitive impairment in Parkinson's disease, the brain mechanisms that underlie the development of these cognitive deficits are unknown."

Dr Collins-Praino is leading a team of researchers who are looking at an association between brain inflammation and Parkinson's disease dementia.

"There is now a growing body of evidence that suggests inflammation in the brain may influence the development of cognitive impairment and dementia in Parkinson's disease," says Dr Collins-Praino.

"While increases in inflammatory markers are usually thought to be associated with negative consequences for cognition, it is also possible that certain aspects of the inflammatory response may protect the brain from damage.

"To address whether particular inflammation may actually protect the brain against in Parkinson's disease, our lab has been comparing levels of inflammation in the brain in Parkinson's patients with and without dementia.

"We've made some exciting findings and once we have a sound understanding of what is going on in the of Parkinson's sufferers, we're hoping to target those pathways to develop an effective treatment for Parkinson's disease dementia," she says.

Explore further: Research targets early symptoms of Parkinson's

Related Stories

Research targets early symptoms of Parkinson's

September 4, 2014
University of Adelaide neuroscience researchers are investigating markers for potential earlier diagnosis and treatment of Parkinson's disease.

Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients

September 18, 2013
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...

Parkinson's disease: Quickly identifying patients at risk of dementia

March 10, 2014
It may now be possible to identify the first-stage Parkinson's patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, ...

Widespread brain atrophy detected in Parkinson's disease with newly developed structural pattern

December 12, 2011
Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson's disease (PD) patients with cognitive impairment, including early decline known as mild cognitive impairment ...

Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease

December 12, 2011
A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease, according to a new study by researchers from the Perelman School of Medicine ...

Gait and dementia link confirmed

October 22, 2014
Researchers at Newcastle University have found a definitive link between gait - the way someone walks - and early changes in cognitive function in people with Parkinson's disease.

Recommended for you

Tapeworm drug could lead the fight against Parkinson's disease

December 12, 2017
Researchers at Cardiff University, in collaboration with the University of Dundee, have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's ...

High-intensity exercise delays Parkinson's progression

December 11, 2017
High-intensity exercise three times a week is safe for individuals with early-stage Parkinson's disease and decreases worsening of motor symptoms, according to a new phase 2, multi-site trial led by Northwestern Medicine ...

Changes in diet may improve life expectancy in Parkinson's patients

November 24, 2017
New research from the University of Aberdeen shows that weight loss in people with Parkinson's disease leads to decreased life expectancy, increased risk of dementia and more dependency on care.

Good cells gone bad: Scientists discover PINK-SNO

November 21, 2017
A new study from The Scripps Research Institute (TSRI) is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction—which can be caused by aging, pesticides and pollution—may contribute ...

Genetic defects in the cell's 'waste disposal system' linked to Parkinson's disease

November 14, 2017
An international study has shed new light on the genetic factors associated with Parkinson's disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of ...

Parkinson's disease: A looming pandemic

November 13, 2017
New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.